BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9468292)

  • 1. Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin.
    Welsh GI; Miller CM; Loughlin AJ; Price NT; Proud CG
    FEBS Lett; 1998 Jan; 421(2):125-30. PubMed ID: 9468292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of translation initiation factor eIF2B by insulin requires phosphatidyl inositol 3-kinase.
    Welsh GI; Stokes CM; Wang X; Sakaue H; Ogawa W; Kasuga M; Proud CG
    FEBS Lett; 1997 Jun; 410(2-3):418-22. PubMed ID: 9237674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycogen synthase kinase-3 is the predominant insulin-regulated eukaryotic initiation factor 2B kinase in skeletal muscle.
    Jefferson LS; Fabian JR; Kimball SR
    Int J Biochem Cell Biol; 1999 Jan; 31(1):191-200. PubMed ID: 10216953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that the dephosphorylation of Ser(535) in the epsilon-subunit of eukaryotic initiation factor (eIF) 2B is insufficient for the activation of eIF2B by insulin.
    Wang X; Janmaat M; Beugnet A; Paulin FE; Proud CG
    Biochem J; 2002 Oct; 367(Pt 2):475-81. PubMed ID: 12133000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine dephosphorylation of glycogen synthase kinase-3 is involved in its extracellular signal-dependent inactivation.
    Murai H; Okazaki M; Kikuchi A
    FEBS Lett; 1996 Aug; 392(2):153-60. PubMed ID: 8772194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of translation initiation factor 2B in control of cell survival by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta signaling pathway.
    Pap M; Cooper GM
    Mol Cell Biol; 2002 Jan; 22(2):578-86. PubMed ID: 11756553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eukaryotic initiation factor 2B: identification of multiple phosphorylation sites in the epsilon-subunit and their functions in vivo.
    Wang X; Paulin FE; Campbell LE; Gomez E; O'Brien K; Morrice N; Proud CG
    EMBO J; 2001 Aug; 20(16):4349-59. PubMed ID: 11500362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylated seryl and threonyl, but not tyrosyl, residues are efficient specificity determinants for GSK-3beta and Shaggy.
    Williams DD; Marin O; Pinna LA; Proud CG
    FEBS Lett; 1999 Apr; 448(1):86-90. PubMed ID: 10217415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activation of eukaryotic initiation factor (eIF)2B by growth factors in PC12 cells requires MEK/ERK signalling.
    Kleijn M; Proud CG
    FEBS Lett; 2000 Jul; 476(3):262-5. PubMed ID: 10913625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of CCK and intracellular calcium to regulate eIF2B and protein synthesis in rat pancreatic acinar cells.
    Sans MD; Kimball SR; Williams JA
    Am J Physiol Gastrointest Liver Physiol; 2002 Feb; 282(2):G267-76. PubMed ID: 11804848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B.
    Welsh GI; Proud CG
    Biochem J; 1993 Sep; 294 ( Pt 3)(Pt 3):625-9. PubMed ID: 8397507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation.
    Stambolic V; Woodgett JR
    Biochem J; 1994 Nov; 303 ( Pt 3)(Pt 3):701-4. PubMed ID: 7980435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of initiation factor eIF-2B by GSK-3 regulated phosphorylation.
    Welsh GI; Loughlin AJ; Foulstone EJ; Price NT; Proud CG
    Biochem Soc Trans; 1997 May; 25(2):191S. PubMed ID: 9191235
    [No Abstract]   [Full Text] [Related]  

  • 14. Nutrients differentially regulate multiple translation factors and their control by insulin.
    Campbell LE; Wang X; Proud CG
    Biochem J; 1999 Dec; 344 Pt 2(Pt 2):433-41. PubMed ID: 10567226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide substrates suitable for assaying glycogen synthase kinase-3 in crude cell extracts.
    Welsh GI; Patel JC; Proud CG
    Anal Biochem; 1997 Jan; 244(1):16-21. PubMed ID: 9025901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wortmannin inhibits the effects of insulin and serum on the activities of glycogen synthase kinase-3 and mitogen-activated protein kinase.
    Welsh GI; Foulstone EJ; Young SW; Tavaré JM; Proud CG
    Biochem J; 1994 Oct; 303 ( Pt 1)(Pt 1):15-20. PubMed ID: 7945234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nerve and epidermal growth factor induce protein synthesis and eIF2B activation in PC12 cells.
    Kleijn M; Welsh GI; Scheper GC; Voorma HO; Proud CG; Thomas AA
    J Biol Chem; 1998 Mar; 273(10):5536-41. PubMed ID: 9488678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of eukaryotic initiation factor eIF2B.
    Proud CG
    Prog Mol Subcell Biol; 2001; 26():95-114. PubMed ID: 11575168
    [No Abstract]   [Full Text] [Related]  

  • 19. T-cell activation leads to rapid stimulation of translation initiation factor eIF2B and inactivation of glycogen synthase kinase-3.
    Welsh GI; Miyamoto S; Price NT; Safer B; Proud CG
    J Biol Chem; 1996 May; 271(19):11410-3. PubMed ID: 8626696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The B cell antigen receptor activates the Akt (protein kinase B)/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase.
    Gold MR; Scheid MP; Santos L; Dang-Lawson M; Roth RA; Matsuuchi L; Duronio V; Krebs DL
    J Immunol; 1999 Aug; 163(4):1894-905. PubMed ID: 10438924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.